https://www.kanner-law.com/court-preliminarily-approves-settlements-in-valsartan-mdl-119-md-02875/
The Court has preliminarily approved three proposed class action settlements in the Valsartan, Losartan, and Irbesartan Products Liability Litigation (MDL...
courtsettlementsvalsartanmdl
https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-valsartan-losartan?utm_campaign=FDA%20publishes%20a%20list%20of%20valsartan-containing%20products%20not%20part%20of%20the%20recall&utm_medium=email&utm_source=Eloqua
Stay informed on FDA updates and press announcements about recalls involving angiotensin II receptor blockers (ARBs) like valsartan and losartan. Discover key...
angiotensin ii receptorfdaupdatespressannouncements
https://www.ajmc.com/view/formulary-placement-led-to-delays-disruptions-in-receiving-sacubitril-valsartan-for-chf
More than a quarter of patients experience disruptions and delays in treatment for chronic heart failure (CHF) after the initial prescription for...
formularyplacementleddelaysreceiving
https://www.elsevier.es/es-revista-medicina-clinica-practica-5-articulo-successful-antihypertensive-treatment-using-sacubitril-valsartan-S2603924923000319
Obstructive sleep apnoea syndrome (O-SAS) induces excessive activity of the sympathetic
in asuccessfulantihypertensivetreatmentusing